Trade Summary

6 days ago, Lee Sung, serving as EVP, CFO at Cytokinetics Inc (CYTK), sold 4,935 shares at $62.15 per share, for a total transaction value of $306,710.00. Following this transaction, Lee Sung now holds 87,127 shares of CYTK.

This sale represents a 5.00% decrease in Lee Sung's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, March 17, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 18, 2026, 1 day after the trade was made.

Cytokinetics Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.